Senior insider sale
President and CEO at MADRIGAL PHARMACEUTICALS, INC. — senior position signals high conviction
$2.98M
7.62K shares
What this filing means
SIBOLD WILLIAM JOHN plans to sell 7.62K shares of MADRIGAL PHARMACEUTICALS, INC. valued at approximately $2.98M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/21/2025ACC: 0001950047-25-006183
DirectorOfficer· President and CEO
Since Mar 2026
7.62K
Shares to sell
$2.98M
Approx. market value
7.62K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
9/8/2024
7.62KTotal acquired7.62K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/8/2024 | Restricted Stock Units N/A | 7.62K | — |
| Total | 7.62K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
7.62K
Market value
$2.98M
8/21/2025
Total
Units
7.62K
Value
$2.98M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/21/2025 | 7.62K | $2.98M | NASDAQ | Planned |
| Total | 7.62K | $2.98M | ||